Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Dow and Cambrex collaborate to manufacture drug-solubility solution
9:00 AM MST | February 15, 2013 | Deepti Ramesh
Cambrex (East Rutherford, NJ) and Dow Chemical have executed an agreement for Cambrex to contract manufacture Dow hydroxypropyl methylcellulose acetate succinate for drug solubility enhancement, the companies say. This is the final step in building on a solubilization partnership that Dow and drug-formulation development and manufacturing company Bend Research (Bend, OR) established last October, and it will help Dow to commercially supply solubility enabling excipients. Construction has already begun on the new operational facility at Cambrex Karlskoga...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee